Discovery of new angiogenesis protein - possible cancer drug target
To grow and spread, tumors need new blood vessels, a process called angiogenesis. One growth factor that causes angiogenesis has been identified - vascular endothelial growth factor or VEGF - and drugs...
View ArticleResearchers focus on finding markers to detect atypical vascular lesions that...
Physicians have long noticed that breast cancer patients who have had surgery or radiation therapy have an heightened risk of developing angiosarcoma, a rare type of cancer that originates in the...
View ArticleWnt1 protein can improve function of endothelial progenitor cells
Circulating through the bloodstream of every human being is a rare and powerful type of cell, one that can actually create new blood vessels to bypass blockages that cause heart attacks and peripheral...
View ArticleMonoclonal antibody inhibits tumor growth in angiosarcoma and breast cancer
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.
View ArticleNew investigational drug offers potential treatment option for lung cancer
PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene,...
View ArticleUNC researchers develop new radiation-free ultrasound technique to detect,...
While ultrasound provides a less expensive and radiation-free alternative to detecting and monitoring cancer compared to technologies such as X-rays, CT scans, and MRIs, ultrasound has seen limited use...
View ArticleResearchers identify two novel genes associated with development of rare,...
Researchers have identified two novel cancer genes that are associated with the development of a rare, highly aggressive, cancer of blood vessels. These genes may now act as markers for future...
View ArticleResearchers find mutated gene responsible for cardiac angiosarcoma in two...
A few years ago, Javier Benítez, director of the Human Genetics Group at the CNIO, received a call from Pablo García Pavía, from the Cardiology Unit of the Puerta de Hierro University Hospital. This...
View ArticleCommon heart drug may halt progression of angiosarcoma
A common heart drug may stop the progression of angiosarcoma, a cancer of the inner lining of blood vessels, according to a study by researchers at Texas Tech University Health Sciences Center El Paso.
View ArticleCommon beta-blocker prescribed for heart conditions has anti-cancer...
Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant anti-cancer properties, say researchers in a new clinical study published in...
View ArticleCancer experts to discuss novel treatment strategies at ESMO Asia 2016 Congress
The ESMO Asia 2016 Congress announces its press programme today. The meeting brings together cancer experts in Singapore, from 16 to 19 December 2016.
View ArticleESMO Asia 2016: Three studies present first data on rare sarcomas in Asian...
The first data on rare sarcomas in Asian patients is presented in three studies today at the ESMO Asia 2016 Congress in Singapore.
View ArticleCommon drug for high blood pressure repurposed to treat soft tissue sarcoma...
A drug that's commonly used to treat high blood pressure is being repurposed for a rare tissue cancer in Europe. The medication, named propranolol, was recently granted Orphan Drug Designation by the...
View ArticleMonoclonal antibody inhibits tumor growth in angiosarcoma and breast cancer
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.
View ArticleNew investigational drug offers potential treatment option for lung cancer
PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene,...
View ArticleUNC researchers develop new radiation-free ultrasound technique to detect,...
While ultrasound provides a less expensive and radiation-free alternative to detecting and monitoring cancer compared to technologies such as X-rays, CT scans, and MRIs, ultrasound has seen limited use...
View ArticleResearchers identify two novel genes associated with development of rare,...
Researchers have identified two novel cancer genes that are associated with the development of a rare, highly aggressive, cancer of blood vessels. These genes may now act as markers for future...
View ArticleResearchers find mutated gene responsible for cardiac angiosarcoma in two...
A few years ago, Javier Benítez, director of the Human Genetics Group at the CNIO, received a call from Pablo García Pavía, from the Cardiology Unit of the Puerta de Hierro University Hospital. This...
View ArticleCommon heart drug may halt progression of angiosarcoma
A common heart drug may stop the progression of angiosarcoma, a cancer of the inner lining of blood vessels, according to a study by researchers at Texas Tech University Health Sciences Center El Paso.
View ArticleCommon beta-blocker prescribed for heart conditions has anti-cancer...
Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant anti-cancer properties, say researchers in a new clinical study published in...
View Article
More Pages to Explore .....